Oncology is the leading sector for AI deals in pharma
Whilst the total value of AI-related deals in pharma has fallen across the board since 2019, oncology's share of the deals has increased (AI deals value $m 2019-2023).
Whilst the total value of AI-related deals in pharma has fallen across the board since 2019, oncology's share of the deals has increased (AI deals value $m 2019-2023).
